Creatine and Perioperative Brain Health

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-75
SponsorMassachusetts General Hospital

About this trial

The goal of this study is to understand the effects of oral creatine supplementation in the perioperative period. Creatine is commonly used to enhance athletic performance, but it can also have positive effects on the brain. Since surgery can lead to alterations in thinking, memory, and attention patterns in some patients, we will assess whether creatine can be protective against these changes in older adults undergoing surgery.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients scheduled for elective surgery under general anesthesia

Disqualifiers

History of creatine deficiency disorders

Severe neurologic or psychiatric diseases

History of stroke or head trauma

Obesity (BMI ≥ 30 kg.m-²), kidney or liver disease

Trial design

Design model

Single group

Treatments tested in this trial

  • Creatine monohydrate

    Dietary supplement

    Participants will receive creatine supplementation before surgery

Treatment groups

80 Participants
are divided into 1 treatment group
Group A: Patients under creatine monohydrate interventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Preoperative cognitive function assessed with the Montreal Cognitive Assessment (MoCA)

The MoCA is a validated tool to assess cognitive function. Scores range from 0-30, with higher scores representing better cognitive function

Time frame
Within three weeks before surgery
2

Postoperative cognitive function assessed with the Montreal Cognitive Assessment (MoCA)

The MoCA is a validated tool to assess cognitive function. Scores range from 0-30, with higher scores representing better cognitive function

Time frame
Within one month after surgery
3

Postoperative cognitive function assessed with the Montreal Cognitive Assessment (MoCA)

The MoCA is a validated tool to assess cognitive function. Scores range from 0-30, with higher scores representing better cognitive function

Time frame
Within three months after surgery
4

Postoperative delirium assessed with the Confusion Assessment Method

The CAM is a validated tool to detect postoperative delirium

Time frame
Up to 7 days after surgery

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: